News

In The News ADVI Leaders Share IRA Insights with Managed Healthcare Executive
In The News Louis Jacques Discusses New Drug Approvals and Reimbursement with Pink Sheet
In The News Seasoned Healthcare Marketing Executive Joins ADVI As Head of Marketing
In The News ADVI Health Welcomes Policy & Reimbursement Expert Brenna Raines
In The News ADVI Expert Speaks With Modern Healthcare About What the IRA Means for PBMs
In The News ADVI Discusses Implications of New Drug Price Bill with Bloomberg Law
In The News ADVI’s Lindsay Bealor Greenleaf told BioWorld that whether the launch interchangeable insulin biosimilars will result in lower costs for patients will be decided by PBMs.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to BioWorld about the latest congressional scrutiny around prescription drug list price increases and the overlooked role played by pharmacy benefit managers.
In The News ADVI’s Lindsay Bealor Greenleaf spoke to AISHealth about CMS’ recent proposal to rein in pharmacy price concessions imposed by pharmacy benefit managers